Tampa General Hospital Adopts Microbot Medical’s LIBERTY Endovascular Robotic System

Reuters02-24
Tampa General Hospital Adopts Microbot Medical’s LIBERTY Endovascular Robotic System

Microbot Medical Inc. said Tampa General Hospital has become the first health system in Florida to adopt its LIBERTY endovascular robotic system following the company’s recent FDA 510(k) clearance. The company noted the adoption occurred during its limited market release and said it plans a full market release at the Society of Interventional Radiology conference in April 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602240830PRIMZONEFULLFEED9659763) on February 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment